Back to discover
Drug

Phosphatidylethanolamine

Research stage
Emerging research
RxNorm470685ChEMBLCHEMBL448115UNII7CMB6B4449
1
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Phosphatidylethanolamine
RxNorm CUI
470685
ChEMBL ID
CHEMBL448115
UNII
7CMB6B4449

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Major research themes7
Cardiovascular Diseases1Inflammasomes1Insulin Resistance1NLR Family, Pyrin Domain-Containing 3 Protein1Phosphatidylcholines1Phosphatidylethanolamines1Ventricular Remodeling1
Journals, researchers & institutions
Top journals
  • Experimental and molecular pathology1
Leading researchers
  • Ambrogi F1
  • Badalyan J1
  • Corsi-Romanelli MM1
  • Dozio E1
  • Kalousová M1
  • Schmitz G1
  • Tacchini L1
  • Tsongalis GJ1
Leading institutions
free-text, unnormalised
  • Dartmouth-Hitchcock Medical Center1
  • Department of Clinical Chemistry and Laboratory Medicine1
  • Department of Clinical Sciences and Community Health1
  • Institute of Medical Biochemistry and Laboratory Diagnostics1
  • Università Degli Studi Di Milano1
  • University of Milan1
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature